Heart failure guidelines recommend four HFrEF medications, but most patients aren’t on the right drugs and doses. See the benefits and how we connect patients with life-improving care.
While people collapse with cardiac arrest during exercise, they typically “crumple” with exercise-induced fainting. Ben Levine, M.D., discusses how to tell the difference and what to do for each.
New AHA guidelines highlight the benefits of SGLT2i medications for patients with heart failure and advances in diagnosing and treating ATTR amyloidosis.
A surprise finding in SGLT2 inhibitor drug research has revealed a potentially groundbreaking heart failure treatment. Learn more from Darren McGuire, M.D.
The concept of regenerating or growing heart tissue is not far-fetched. Ongoing research by UT Southwestern's Hesham Sadek, M.D., Ph.D., may potentially change the future of care for patients with mild to moderate heart disease.
Division I softball player Kaitlynn Dawson faced open heart surgery for a leaky bicuspid aortic valve. See how the less-invasive SAVR procedure by UT Southwestern's Dr. Neelan Doolabh got Kaitlynn back on the field in just three months – with a brand new heart valve.
Video visits are an effective, high-quality alternative to in-clinic visits for patients with advanced heart failure. Find out what to expect and how remote care can benefit patients.
Imagine driving through a tunnel. On Monday, you encounter a pile of rubble. There is a narrow gap, big enough to drive through. On Tuesday, you’re driving through the tunnel and find
Shelley Lynne had an aortic root aneurysm, a leaky heart valve, and no room in her life for traditional open heart surgery and a long recovery. See how a new procedure designed by UT Southwestern's Neelan Doolabh, M.D., saved Shelley's life – and livelihood.
After years of steady decline, heart disease death rates have increased 1.5% among the 45-60 age group – right in the prime of their personal and professional lives. In this MedBlog, Amit Khera, M.D., discusses the major causes and how preventive cardiology can help reverse this alarming trend.
Left ventricular assist devices (LVAD) can help patients with advanced heart failure live longer and give them a better quality of life. Dr. Alpesh Amin answers four common questions he gets from patients about LVADs.
A landmark study has confirmed that, in certain patients with chest pain and abnormal stress tests, drug therapy can be just as effective as bypass or stents to prevent heart attack. In this MedBlog, James De Lemos, M.D., discusses how the findings can help patients save time and money, plus reduce unnecessary risks.
